Ron Suskind is a Pulitzer Prize-winning journalist and best-selling author, lecturer at Harvard Law School, and founder and chief executive officer of The Affinity Project/Sidekicks, a developer of augmentative technologies for ‘at need’ populations, starting with autism.
Ron Suskind
Founder
The Affinity Project/Sidekicks
From this contributor
Animated sidekick connects parents to children with autism
In a new type of therapy for autism, parents talk or type into their phone or computer, and their words emerge in the voice of an animated character.
Animated sidekick connects parents to children with autism
By
Ron Suskind
21 February 2017 | 9 min read
Explore more from The Transmitter
Autism prevalence increasing in children, adults, according to electronic medical records
The uptick from 2011 to 2022 in the United States underscores a need for more services and research, the investigators say.
Autism prevalence increasing in children, adults, according to electronic medical records
The uptick from 2011 to 2022 in the United States underscores a need for more services and research, the investigators say.
By
Shaena Montanari
21 November 2024 | 2 min read
Immune cell interlopers breach—and repair—brain barrier in mice
The choroid plexus, the protective network of blood vessels and epithelial cells that line the brain’s ventricles, recruits neutrophils and macrophages during inflammation, a new study shows.
Immune cell interlopers breach—and repair—brain barrier in mice
The choroid plexus, the protective network of blood vessels and epithelial cells that line the brain’s ventricles, recruits neutrophils and macrophages during inflammation, a new study shows.
By
Claudia López Lloreda
20 November 2024 | 6 min read
Expanding set of viral tools targets almost any brain cell type
Harmless viruses that encase short noncoding DNA elements called enhancers enable cell-type-specific gene delivery across the central nervous system in rodents and primates.
Expanding set of viral tools targets almost any brain cell type
Harmless viruses that encase short noncoding DNA elements called enhancers enable cell-type-specific gene delivery across the central nervous system in rodents and primates.
By
Holly Barker
19 November 2024 | 2 min watch